Bird Flu Strain H9N2: A Potential Threat to Humans A team of scientists has raised concerns about the H9N2 bird flu virus, which has adapted to human cells, posing a potential risk of a hu…
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are attending the U.S. Olympic and Paralympic Committee Team USA Medi…
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announ…
Swift Solar Deploys Perovskite Modules at DoD Cyber Exercise Swift Solar, a US solar technology company, has deployed perovskite solar tec…
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …
South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir,…
Chick-fil-A Introduces Hospital Vending Machine Fast-food giant Chick-fil-A has launched its first-ever vending machine, sparking debate a…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…